Arthur Aung

105 posts

Arthur Aung

Arthur Aung

@Arthur_Aung

Hematology Oncology Fellow | Northwell Health Northshore/LIJ Hospital

New York, USA เข้าร่วม Temmuz 2012
1.2K กำลังติดตาม213 ผู้ติดตาม
Arthur Aung รีทวีตแล้ว
Isabel Preeshagul
Isabel Preeshagul@ipreeshagul·
A VERY applicable case presented by THE AMAZING @NagashreeSeeth1 of discovering Met amp. A reminder to 👀 for MET and HER IHC on all our patients. We have approvals for these with TELISO-V and TDX-D #NYL25 @gotoPER @NorthwellHealth
Isabel Preeshagul tweet media
English
2
2
11
748
Arthur Aung
Arthur Aung@Arthur_Aung·
Grateful to work with @NagashreeSeeth1 and colleagues on developing ICTIS. Clinical trial eligibility criteria often exclude patients with comorbidities or autoimmune disease. ICTIS score provides a standardized way to measure and track inclusivity in advanced NSCLC immunotherapy trial -a step toward more equitable and representative research. #LCSM #ClinicalTrials
Nagashree Seetharamu@NagashreeSeeth1

Increasing inclusivity of clinical trials- long way to go! Check out our findings and a proposed inclusivity score in JTO-CRR @IASLC

English
1
1
5
483
Arthur Aung รีทวีตแล้ว
Jarushka Naidoo
Jarushka Naidoo@DrJNaidoo·
💡Starting out in thoracic oncology? The @IASLC Communications Committee proudly brings you: ‘50 Years of Progress in NSCLC: A New Fellow’s Guide in the Clinic’ A whistlestop tour of key advances, distilled by global leaders @JTOonline @OncoAlert #LCSM jto.org/article/S1556-…
English
7
37
112
24K
Arthur Aung
Arthur Aung@Arthur_Aung·
When I was born, cisplatin + RT had just become the post-op standard for high-risk LA-SCCHN. It has stayed that way for 30 years. As a fellow, it’s meaningful to witness real progress. Immunotherapy is finally entering. A new era is starting for #HNSCC #ASCO25
Arthur Aung tweet media
English
0
0
5
270
Arthur Aung
Arthur Aung@Arthur_Aung·
Amazing work for metastatic HNSCC—excited to see BV + Pembro showing promise in the frontline setting! Congrats to authors @omarabughanimeh @onclive #ASCO25 #HeadAndNeckCancer
Omar Abu Ghanimeh@omarabughanimeh

Proud to be an investigator in the head and neck cohort of SGN35-033. Our data was discussed today at @ASCO, showing promising clinical efficacy of BV + Pembro in treatment -naive patients with metastatic HNSCC and CPS ≥1. meetings.asco.org/abstracts-pres… @NebraskaMed @UNMCHemeOnc

English
0
0
4
235
Arthur Aung รีทวีตแล้ว
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
Dr. Pasi Janne at #ASCO25 with update on KRYSTAL7: phase II study of first line adagrasib plus pembrolizumab for #KRAS G12C NSCLC. RR 44% (61% for PDL1 high). mDOR 26.3m, PFS 11m (27.7m for PDL1 high), OS 18.3m. 17% had to stop pembro for TRAE.
Stephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet media
English
0
25
57
4K
Arthur Aung
Arthur Aung@Arthur_Aung·
Thanks so much, @dominicandoc2 ! 🙏 Means the world to have your support. Grateful for friends who show up, cheer loud, and walk this journey with me through the hard work and the dream 💪🧠🚀 Big thanks to @OncLive and @BioAscend #NextWaveForum for bringing us together!
Abner Antonio Murray, MD PhD@dominicandoc2

Huge congrats to my friend Dr. Wint Yan Arthur Aung @Arthur_Aung for presenting his meta-analysis on sotorasib dosing in KRAS G12C–mutated #NSCLC at #ASCO25! 🧬🔥 📊 Key findings: — 960 mg dose = higher ORR but — ⚠️ More toxicity, dose reductions, and discontinuations — ❌ No significant PFS benefit with higher dose 💡 His work underscores the need for adaptive, individualized dosing strategies to keep patients on treatment longer—safely and effectively. Proud to see fellows driving change in lung cancer care! #LungCancer #KRAS #TargetedTherapy #ASCO25 #OncologyFellows

English
0
0
2
157
Arthur Aung รีทวีตแล้ว
Abner Antonio Murray, MD PhD
Abner Antonio Murray, MD PhD@dominicandoc2·
🎬 Behind the scenes at the @OncBrothers x @SignifyMD shoot with @Jani_Chinmay and @COLazagasti—filming this was a blast! 🔊 Sharp clinical insights, effortless chemistry, and plenty of laughs between takes. They dive into real-world #EGFR sequencing strategies and the evolving role of #tarlatamab even outside academic centers. A must-watch for anyone navigating biomarker-driven care in lung cancer. 🧬💡 Stay tuned—the full convo drops soon, and you won’t want to miss it. 🎤📹🔥 @SylvesterCancer @HemOncMiami #LCSM #OncTwitter #MedEd
Abner Antonio Murray, MD PhD tweet mediaAbner Antonio Murray, MD PhD tweet mediaAbner Antonio Murray, MD PhD tweet media
English
0
6
10
3.4K